On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks ... more ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...

--Longest losing streak since Aug. 5, 2022, when it fell for six straight trading days --Worst six day stretch since the six days ending March 25, 2020, when it fell 14.85% --Down 19.3% from its ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

A stock split divides existing shares into multiple new ones, increasing a given company’s share count and making shares more ...

Trading on Wall Street was mixed early as companies reported their latest earnings with widely varying results ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q3 2024 earnings call. [Operator ...

We’re maintaining our fair value estimate of $580 per share for Eli Lilly LLY following the firm’s somewhat disappointing third-quarter results. We think most of the pressure on GLP-1 sales results ...